Overview

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

Status:
Not yet recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

This study evaluates the long-term anticoagulation with oral factor Xa inhibitor versus vitamin K antagonist in patients receiving a mechanical aortic valve replacement.

Phase:

Phase 4

Details

Lead Sponsor:

Joon Bum Kim

Treatments:

Apixaban
Factor Xa Inhibitors
Vitamin K
Vitamins
Warfarin